Assessing the quality of evidence from epidemiological agent-based models for the COVID-19 pandemic
Agent-based models (ABMs) are one of the main sources of evidence for decisions regarding mitigation and suppression measures against the spread of SARS-CoV-2. These models have not been previously included in the hierarchy of evidence put forth by the evidence-based medicine movement, which prioritizes those research methods that deliver results less susceptible to the risk of confounding. We point out the need to assess the quality of evidence delivered by ABMs and ask the question of what is the risk that assumptions entertained in ABMs do not include all the key factors and make model predictions susceptible to the problem of confounding.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
History and philosophy of the life sciences - 43(2021), 1 vom: 20. Jan., Seite 10 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Maziarz, Mariusz [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 27.01.2021 Date Revised 24.03.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s40656-020-00357-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320335739 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320335739 | ||
| 003 | DE-627 | ||
| 005 | 20231225173345.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40656-020-00357-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1067.xml |
| 035 | |a (DE-627)NLM320335739 | ||
| 035 | |a (NLM)33471199 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Maziarz, Mariusz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Assessing the quality of evidence from epidemiological agent-based models for the COVID-19 pandemic |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.01.2021 | ||
| 500 | |a Date Revised 24.03.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Agent-based models (ABMs) are one of the main sources of evidence for decisions regarding mitigation and suppression measures against the spread of SARS-CoV-2. These models have not been previously included in the hierarchy of evidence put forth by the evidence-based medicine movement, which prioritizes those research methods that deliver results less susceptible to the risk of confounding. We point out the need to assess the quality of evidence delivered by ABMs and ask the question of what is the risk that assumptions entertained in ABMs do not include all the key factors and make model predictions susceptible to the problem of confounding | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Agent-based models | |
| 650 | 4 | |a EBM | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Zach, Martin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t History and philosophy of the life sciences |d 1993 |g 43(2021), 1 vom: 20. Jan., Seite 10 |w (DE-627)NLM002616416 |x 1742-6316 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2021 |g number:1 |g day:20 |g month:01 |g pages:10 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40656-020-00357-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2021 |e 1 |b 20 |c 01 |h 10 | ||